Serum alkaline phosphatase and urinary hydroxyproline values in children receiving phenobarbital with and without

Insights

Phenobarbital use in children receiving anticonvulsants may increase rickets risk by altering bone metabolism markers. Daily vitamin D supplementation appears crucial for preventing or reversing these biochemical changes.

Area of Science:

  • Pediatric Endocrinology
  • Clinical Pharmacology
  • Biochemistry

Background:

  • Anticonvulsive medications are frequently prescribed for prolonged periods in children.
  • Concerns exist regarding the potential skeletal side effects of long-term anticonvulsant therapy, specifically rickets.
  • Phenobarbital is a commonly used anticonvulsant with a known impact on vitamin D metabolism.

Purpose of the Study:

  • To investigate the effect of phenobarbital on biochemical markers associated with rickets development in children on long-term anticonvulsant therapy.
  • To assess the efficacy of vitamin D supplementation in mitigating phenobarbital-induced biochemical derangements.

Main Methods:

  • Serum alkaline phosphatase (AP) and total urinary hydroxyproline (HOP) levels were measured in 36 children.
  • Children were receiving anticonvulsive medications, with a focus on phenobarbital administration.
  • Intervention included a single large dose of vitamin D and a two-month daily regimen of 4,000 IU vitamin D.

Main Results:

  • Phenobarbital administration rapidly increased AP and HOP values, indicating early biochemical changes suggestive of rickets, even without overt bone abnormalities.
  • A single large oral dose of vitamin D did not correct these biochemical alterations.
  • Daily vitamin D (4,000 IU for two months) effectively prevented or reversed latent rickets changes in children on anticonvulsants.

Conclusions:

  • Phenobarbital administration is strongly implicated in the development of rickets in children undergoing long-term anticonvulsant treatment.
  • Daily vitamin D supplementation is essential for children receiving anticonvulsive drugs to prevent or manage rickets.
  • Monitoring bone metabolism and ensuring adequate vitamin D intake are critical in this patient population.

Related Concept Videos

Introduction to Electrolytes01:33

Introduction to Electrolytes

In humans, electrolytes play a vital role in various physiological processes. Balancing electrolyte levels is essential for normal body functions; their imbalance can be life-threatening. The major electrolytes include sodium, potassium, chloride, calcium, phosphate, and bicarbonate. They are primarily involved in physiological processes, such as nerve signal transmission, membrane trafficking, muscle contraction, buffering body fluids, and balancing water levels in the body.
Role of Sodium
One...
Role of Vitamins in Maintaining Bone Health01:25

Role of Vitamins in Maintaining Bone Health

The growth and maintenance of bone are regulated by a combination of nutritional factors, including vitamins, such as vitamin A, B12, C, D, and K.
Vitamin A
Vitamin A is involved in the process of bone remodeling. Retinoic acid, the active metabolite of Vitamin A, has nuclear receptors in osteoblasts and osteoclasts, which are involved in bone remodeling.
Vitamin B12
Vitamin B12 acts as a cofactor during the formation of osteoblast-related proteins, such as osteocalcin. Vitamin B12 plays a role...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
Serum Studies: Renal Function Tests01:24

Serum Studies: Renal Function Tests

Renal function tests are crucial for assessing kidney health, monitoring disease progression, and evaluating the kidneys' efficiency in waste elimination, fluid balance, and electrolyte regulation. These tests offer critical insights into kidney function, even though routine measurements may appear normal until there is a significant decline in the glomerular filtration rate or GFR. Typically, signs of kidney impairment only become evident when the GFR falls to about 50% of its normal level.